Profile
ABVX VRTX REGN SGEN ALNY ARGX
Company Name ABIVAX SA Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Seagen Inc. Alnylam Pharmaceuticals, Inc. argenx SE
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $398.90M $130.72B $60.54B $43.15B $35.25B $34.28B
Employees 0.07K 6.10K 15.11K 3.26K 2.23K 1.60K
CEO Mr. Marc M. P. de Garidel M.B.A. Dr. Reshma Kewalramani FASN, M.D. Dr. Leonard S. Schleifer M.D., Ph.D. Mr. David R. Epstein B.Sc., M.B.A. Dr. Yvonne L. Greenstreet M.B.A., M.D. Mr. Timothy Van Hauwermeiren EMBA, M.Sc.
Ratings
ABVX VRTX REGN SGEN ALNY ARGX
Quant Rating Score 1 2 4 3 1 3
Quant Rating Strong Sell Sell Buy Neutral Strong Sell Neutral
Trading
ABVX VRTX REGN SGEN ALNY ARGX
Last Close $6.4 $489.1 $563.16 $228.74 $234.56 $596.2
High 52 $15.89 $516.74 $1201.76 $228.74 $296.75 $671.75
Low 52 $5.24 $392.81 $546.39 $228.74 $143.31 $356.01
Price vs. 52 Week High -59.72 % -5.35 % -53.14 % 0 % -20.96 % -11.25 %
Price vs. 52 Week Low 22.14 % 24.51 % 3.07 % 0 % 63.67 % 67.47 %
Total Return
ABVX VRTX REGN SGEN ALNY ARGX
1 Month Return -5.6 % -4.52 % -15.34 % 0 % -3.99 % -2.45 %
3 Month Return 3.9 % 15.9 % -17.37 % 0 % -4.75 % -6.92 %
6 Month Return -38.76 % 1.26 % -43.15 % 0 % -20.74 % 5.52 %
9 Month Return -50.19 % 0.2 % -47.23 % 0 % -0.9 % 27.79 %
YTD Return -12.57 % 21.46 % -20.94 % 0 % -0.32 % -3.06 %
1 Year Return -57.64 % 24.3 % -37.01 % 0 % 61.59 % 66.35 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
ABVX VRTX REGN SGEN ALNY ARGX
Dividend Yield Percentage (TTM) - - 0.16 % - - -
Dividend Paid and Capex Coverage Ration (TTM) -438.26 % -1.65 % 5.37 % -2.27 % -0.24 % -44.32 %
Dividend Per Share (TTM) - - 0.88 % - - -
Payout Ratio (TTM) - - - - - -
Profitability
ABVX VRTX REGN SGEN ALNY ARGX
Gross Profit Margin TTM 95.81 % 86.09 % 84.47 % 72.37 % 85.62 % 46.33 %
Return on Assets TTM -62.37 % -2.38 % 11.69 % -11.76 % -6.56 % 13.45 %
Return on Equity TTM -110.04 % -3.28 % 14.77 % -16.53 % 905.33 % 16.83 %
Return on Capital Employed TTM -83.2 % -1.3 % 10.89 % -16.87 % -5.79 % -0.31 %
Net Income Per EBT TTM 98.52 % -215.53 % 92.32 % 100.55 % 73.71 % 25990.14 %
EBT Per Ebit TTM 105.83 % -100.69 % 118.85 % 94.01 % 213.34 % -18.79 %
EBIT Per Revenue TTM -1884.33 % -2.24 % 28.32 % -36.09 % -7.87 % -0.77 %
Cash Flow To Debt Ratio TTM -136.47 % -28.16 % 222.76 % -185.98 % -0.64 % -201.37 %
Receivables Turnover TTM - 6.84 2.29 1.98 5.55 2.46
Payables Turnover TTM 0.02 3.71 2.79 1.54 3.66 1.83
Inventory Turnover TTM - 1.27 0.71 0.65 4.12 2.93
Fixed Asset Turnover TTM 350.85 % 425.82 % 308.76 % 256.83 % 323.99 % 5106.8 %
Asset Turnover TTM 3.17 % 48.84 % 37.61 % 34.46 % 53.02 % 35.83 %
Operating Cash Flow Per Share TTM -2.46 -1.91 41.08 -1.12 -0.06 -1.07
Free Cash Flow Per Share TTM -2.46 -3.07 33.43 -1.62 -0.33 -1.09
Cash Per Share TTM 353.34 % 2375.11 % 16647.4 % 657.5 % 2095.42 % 4597.04 %
Operating Cash Flow Sales Ratio TTM -1713.06 % -4.48 % 31.13 % -16.85 % -0.37 % -3.54 %
Free Cash Flow Operating Cash Flow Ratio TTM 100.23 % 160.43 % 81.38 % 144.14 % 512.38 % 102.26 %
Cash Flow Coverage Ratios TTM -136.47 % -28.16 % 222.76 % -185.98 % -0.64 % -201.37 %
Price To Free Cash Flows Ratio TTM -2.2 -165.4 16.83 -141.85 -827.74 -444.85
Price To Operating Cash Flows Ratio TTM -2.18 -266.09 13.71 -203.89 -4192.79 -531.16
Price Cash Flow Ratio TTM -2.18 -266.09 13.71 -203.89 -4192.79 -531.16
Income Statement (TTM)
ABVX VRTX REGN SGEN ALNY ARGX
Revenue $0B $11.02B $14.2B $1.96B $2.25B $2.19B
Gross Profit $0B $9.49B $12.23B $1.55B $1.92B $1.96B
Gross Profit Ratio 84.7% 86.11% 86.13% 79.1% 85.62% 89.62%
EBITDA $-0.13B $0.49B $5.32B $-0.62B $-0.18B $0B
Net Income $-0.15B $-0.54B $4.41B $-0.61B $-0.28B $0.83B
EPS Diluted -3.43 -2.08 38.34 -3.3 -2.16 12.78
Balance Sheet (MRQ)
ABVX VRTX REGN SGEN ALNY ARGX
Long Term Debt $0.05B $1.66B $2.7B $0.04B $0B $0.03B
Total Liabilities $0.16B $6.12B $8.41B $0.87B $4.17B $0.68B
Total Equity $0.04B $16.41B $29.35B $2.8B $0.07B $5.31B
Total Investments $0B $6.65B $6.52B $1.42B $1.73B $1.82B
Total Debt $0.1B $1.75B $2.7B $0.04B $1.3B $0.04B
Total Assets $0.21B $22.53B $37.76B $3.67B $4.24B $5.99B
Cash Flow Statement (TTM)
ABVX VRTX REGN SGEN ALNY ARGX
Net Income $-0.18B $-0.54B $4.41B $-0.61B $-0.28B $0.8B
Inventory $0B $-0.52B $-0.62B $-0.23B $0.01B $-0.09B
Dividends Paid $0B $0B $0B $0B $0B $0B
Operating Cash Flow $-0.15B $-0.49B $4.42B $-0.45B $-0.01B $-0.08B
Capital Expenditure $-0B $-0.3B $-0.76B $-0.08B $-0.03B $-0B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 18.72
ABCL AbCellera Biologics Inc. 2.42
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 4.84
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 0.9008
ABPWW 0.0465
ABSI Absci Corporation 3.09
ABUS Arbutus Biopharma Corporation 3.15
ABVC ABVC BioPharma, Inc. 0.855
ACAD ACADIA Pharmaceuticals Inc. 14.73
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.5258
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 1.99
ACIU AC Immune SA 1.48
ACLX Arcellx, Inc. 62.02
ACRV Acrivon Therapeutics, Inc. Common Stock 1.81
ETFs With Exposure to ABVX
Ticker ETF Name Weight Percentage Price
DBEZ Xtrackers MSCI Eurozone Hedged Equity ETF 0 47.37
BOUT Innovator IBD Breakout Opportunities ETF 2.56 33.4339
SPEU SPDR Portfolio Europe ETF 0.001346 43.84
SXRJ.DE iShares VII PLC - iShares MSCI EMU Small Cap UCITS ETF EUR (Acc) 0.0665 278.6
CES1.L iShares VII PLC - iShares MSCI EMU Small Cap UCITS ETF EUR (Acc) 0.0539 23907.5
Unlock